Study to Determine the Concentrations of Maraviroc in Semen, the Seminal to Plasma Ratio of Maraviroc and the Variability in Seminal to Plasma Ratios Over the Maraviroc Dosing Period.
Phase of Trial: Phase I
Latest Information Update: 08 Sep 2014
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- 13 Jun 2012 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 04 Jun 2012 Planned end date changed from 1 Jul 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov record.
- 09 Dec 2009 Planned end date (1 Jul 2010) added as reported by ClinicalTrials.gov record (NCT01009034).